Cargando…

Effects of induction chemotherapy on nutrition status in locally advanced nasopharyngeal carcinoma: a multicentre prospective study

BACKGROUND: Induction chemotherapy (IC) and concurrent chemoradiotherapy (CCRT) is the standard of care for locoregionally advanced nasopharyngeal carcinoma (LA‐NPC). This intensive treatment regimen increases acute toxicities, which could negatively impact patients' nutritional status. We cond...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miao, Jingjing, Wang, Lin, Ong, Enya H.W., Hu, Chaosu, Lin, Shaojun, Chen, Xiaozhong, Chen, Yuanyuan, Zhong, Yahua, Jin, Feng, Lin, Qin, Lin, Shaomin, Hu, Xuefeng, Zhang, Ning, Wang, Rensheng, Wang, Cong, Guo, Xiang, Yit, Nelson L.F., Shi, Hanping, Tan, Sze Huey, Mai, Haiqiang, Xie, Conghua, Chua, Melvin L.K., Zhao, Chong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067484/ https://www.ncbi.nlm.nih.gov/pubmed/36872457 http://dx.doi.org/10.1002/jcsm.13196

Ejemplares similares

Development of a risk classification system combining TN-categories and circulating EBV DNA for non-metastatic NPC in 10,149 endemic cases
por: Chen, Fo-Ping, et al.
Publicado: (2021)

Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized Clinical Trial
por: Miao, Jingjing, et al.
Publicado: (2022)

Surgery as an alternative to radiotherapy in early‐stage nasopharyngeal carcinoma: innovation at the expense of uncertainty
por: Huang, Luo, et al.
Publicado: (2020)

The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
por: Li, You Quan, et al.
Publicado: (2018)

Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors
por: Wu, Qiuji, et al.
Publicado: (2020)

Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives
por: Lang, Jinyi, et al.
Publicado: (2019)

Salvage Intensity-Modulated Radiation Therapy (IMRT) for Locally Recurrent Nasopharyngeal Cancer after Definitive IMRT: A Novel Scenario of the Modern Era
por: Kong, Lin, et al.
Publicado: (2016)

The incidence and prognosis of nasopharyngeal carcinoma patients with family history
por: Wang, Yansu, et al.
Publicado: (2017)

Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue
por: Niu, Xiaoshuang, et al.
Publicado: (2013)

Variations of Clinical Target Volume Delineation for Primary Site of Nasopharyngeal Cancer Among Five Centers in China
por: Zhang, Shichuan, et al.
Publicado: (2020)

Outcomes in Radiotherapy-Treated Patients With Cancer During the COVID-19 Outbreak in Wuhan, China
por: Xie, Conghua, et al.
Publicado: (2020)

Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma
por: Kong, Fangfang, et al.
Publicado: (2018)

Involvement of both Cervical Lymph Nodes and Retropharyngeal Lymph Nodes has prognostic value for N1 patients with Nasopharyngeal Carcinoma
por: Shi, Qi, et al.
Publicado: (2014)

Retreatment in locally recurrent nasopharyngeal carcinoma: Current status and perspectives
por: Poh, Sharon Shuxian, et al.
Publicado: (2021)

The feasibility of omitting irradiation to the contralateral lower neck in stage N1 nasopharyngeal carcinoma patients
por: Hu, Weixu, et al.
Publicado: (2013)

Circulating Tumor Cells: A Promising Biomarker in the Management of Nasopharyngeal Carcinoma
por: Wu, Jiangtao, et al.
Publicado: (2021)

Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results
por: Hu, Jiyi, et al.
Publicado: (2018)

Prognostic values of hematological biomarkers in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy
por: Ye, Lulu, et al.
Publicado: (2018)

An evaluation of concordance between head and neck advanced practice radiation therapist and radiation oncologists in toxicity assessment for nasopharyngeal carcinoma patients
por: Sin, S.Y., et al.
Publicado: (2021)

Association of the rs2071559 (T/C) polymorphism with lymphatic metastasis in patients with nasopharyngeal carcinoma
por: Hu, Kai, et al.
Publicado: (2017)

Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma
por: Huang, Luo, et al.
Publicado: (2020)

Effect of COVID-19 Epidemic on Delay of Diagnosis and Treatment Path for Patients with Nasopharyngeal Carcinoma
por: Yang, Youqi, et al.
Publicado: (2020)

Intensity-modulated radiotherapy combined with sequential cisplatin and fluorouracil chemotherapy for locoregionally advanced nasopharyngeal carcinoma
por: Wu, Mingyao, et al.
Publicado: (2018)

Long-term Patterns of Regional Failure for Nasopharyngeal Carcinoma following Intensity-Modulated Radiation Therapy
por: Xue, Fen, et al.
Publicado: (2017)

Second Primary Lung Adenocarcinoma After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
por: Xue, Fen, et al.
Publicado: (2022)

miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma
por: Jiang, Li, et al.
Publicado: (2021)

Comparison of radiomics tools for image analyses and clinical prediction in nasopharyngeal carcinoma
por: Liang, Zhong-Guo, et al.
Publicado: (2019)

Local regression and control of T1‐2 nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy
por: Xue, Fen, et al.
Publicado: (2018)

Predictive single nucleotide polymorphism markers for acute oral mucositis in patients with nasopharyngeal carcinoma treated with radiotherapy
por: Le, Ziyu, et al.
Publicado: (2017)

Omission of Chemotherapy in Early Stage Nasopharyngeal Carcinoma Treated with IMRT: A Paired Cohort Study
por: Xu, Tingting, et al.
Publicado: (2015)

Nasopharyngeal carcinoma with central nervous system metastases: Two case reports and a review of the literature
por: Shen, Chunying, et al.
Publicado: (2017)

Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis
por: Han, Shuting, et al.
Publicado: (2022)

Prognostic value of nutritional markers in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy: a propensity score matching study
por: Oei, Ronald Wihal, et al.
Publicado: (2018)

Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3–4 nasopharyngeal carcinoma
por: Xue, Fen, et al.
Publicado: (2017)

Particle beam therapy for nasopharyngeal cancer: A systematic review and meta-analysis
por: Ng, Wai Tong, et al.
Publicado: (2022)

Prognostic value of inflammation-based prognostic index in patients with nasopharyngeal carcinoma: a propensity score matching study
por: Oei, Ronald Wihal, et al.
Publicado: (2018)

Pre-treatment Serum Lactate Dehydrogenase is Predictive of Survival in Patients with Nasopharyngeal Carcinoma Undergoing Intensity-Modulated Radiotherapy
por: Oei, Ronald Wihal, et al.
Publicado: (2018)

Germline Variants Associated with Nasopharyngeal Carcinoma Predisposition Identified through Whole-Exome Sequencing
por: Lee, Ning-Yuan, et al.
Publicado: (2022)

Development and validation of a model for temporal lobe necrosis for nasopharyngeal carcinoma patients with intensity modulated radiation therapy
por: Wang, Jiazhou, et al.
Publicado: (2019)

LAPTM4B knockdown increases the radiosensitivity of EGFR-overexpressing radioresistant nasopharyngeal cancer cells by inhibiting autophagy
por: Chu, Chu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ui563cefglpeoni3angpcc45hr